Palleon Pharmaceuticals, a clinical-stage company leading innovation in glyco-immunology for autoimmune diseases and cancer, today announced results from the Phase 1/2 GLIMMER-01 trial of E-602. This first-in-class human sialidase enzyme therapeutic was tested in combination with the PD-1 inhibitor cemiplimab…
Sunshine Health, Florida’s largest managed care organization and a subsidiary of Centene Corporation (NYSE: CNC), has announced the appointment of Charlene Zein as Plan President and Chief Executive Officer, effective November 3, 2024. With nearly 20 years of experience in…
Tempus AI, Inc. (NASDAQ: TEM), a leader in AI-driven precision medicine, has announced the clinical launch of its Immune Profile Score (IPS) algorithmic test. Now available for clinicians to order, the IPS test is a multimodal biomarker designed to serve…
Square Knot Health, a leader in technology-driven kidney transplant care, has achieved outstanding results with its innovative care model designed to help patients navigate the complexities of kidney transplantation. The company’s unique approach streamlines the transplant process, improving access and…
Cofactor Genomics, Inc., a clinical-stage company focused on advancing precision medicine through RNA decoding, has announced the publication of results from its PREDAPT clinical trial (NCT04510129) in head and neck squamous cell carcinoma (HNSCC). The study highlights the clinical validity…
Maravai LifeSciences, Inc. (NASDAQ: MRVI), a global provider of life science reagents and services, has announced an agreement to acquire the DNA and RNA business of Officinae Bio. This acquisition is expected to enhance Maravai and its subsidiary, TriLink BioTechnologies,…
GE HealthCare Technologies Inc. (Nasdaq: GEHC) announced today the launch of a secondary underwritten public offering of 13,281,302 shares of its common stock (the “GEHC Shares”). The company is not selling any shares and will not receive any proceeds from…
BioIVT, a global leader in biospecimen solutions and research support for drug and diagnostic development, has announced an exclusive partnership with KRISHGEN BioSystems. KRISHGEN, a prominent provider of life science research tools and services with over two decades of experience…
SBC Medical Group Holdings (California, USA, CEO: Aikawa Yoshiyuki), a provider of management support to medical institutions globally, has entered into a business partnership with MEDIROM Corporation (Headquarters: Minato-ku, Tokyo, CEO: Eguchi Koji). MEDIROM operates over 300 relaxation studios nationwide…
Key Financial Highlights for Q3 2024: Recent Operating Highlights: CEO Comments: “We had another record quarter, driven by significant reimbursement tailwinds for Guardant360 and strong volume growth,” said Helmy Eltoukhy, co-founder and co-CEO. “With this momentum, we’re raising our revenue…
NovaBay® Pharmaceuticals, Inc. (NYSE American: NBY) (“NovaBay”) announced today that it has accepted a revised offer from PRN Physician Recommended Nutriceuticals, LLC (“PRN”) to raise the base purchase price for its eyecare business from $9.5 million to $11.5 million. The…
Minds + Assembly has announced its strategic partnership with BOLDSCIENCE, a full-service medical communications agency, to expand its world-class healthcare communications and commercialization platform. The collaboration will enhance Minds + Assembly’s ability to serve pharma, biotech, medical device, and digital…